Avedro, Inc. (AVDR)

Home » Stocks » Avedro

Nov 21, 2019 - AVDR merged into GKOS

Stock Price: $22.99 USD 0.00 (0.00%)

Updated Jan 6, 2020 4:00 PM EST

• Overview
• Financials

Key Info

Market Cap	n/a
Revenue (ttm)	n/a
Net Income (ttm)	n/a
Shares Out	n/a
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Dividend Yield	n/a

Stock Quote

Trading Day	Jan 6, 2020
Last Price	$22.99
Previous Close	$22.99
Change ($)	0.00
Change (%)	0.00%
Day's Open	-
Day's Range	22.99 - 22.99
Day's Volume	0
52-Week Range	10.75 - 27.51

More Stats

Market Cap	n/a
Enterprise Value	n/a
Earnings Date (est)	n/a
Ex-Dividend Date	n/a
Shares Outstanding	n/a
Float	n/a
EPS (basic)	n/a
EPS (diluted)	n/a
FCF / Share	n/a

Dividend	n/a
Dividend Yield	n/a
Earnings Yield	n/a
FCF Yield	n/a
Payout Ratio	n/a
Shares Short	n/a
Short Ratio	n/a
Short % of Float	n/a
Beta	n/a

PE Ratio	n/a
Forward PE	n/a
P/FCF Ratio	n/a
PS Ratio	n/a
PB Ratio	n/a
Revenue	n/a
Operating Income	n/a
Net Income	n/a
Free Cash Flow	n/a

Net Cash	32.21M
Net Cash / Share	n/a
Gross Margin	n/a
Operating Margin	n/a
Profit Margin	n/a
FCF Margin	n/a
ROA	n/a
ROE	n/a
ROIC	n/a

Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (1)

Buy	0
Overweight	0
Hold	1
Underweight	0
Sell	0

What these ratings mean

Analyst Consensus: Hold

Price Target

$26.00*

Low

26.0

Current: $22.99

High

26.0

Target: 26.00

*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Income Statement | Balance Sheet | Cash Flow

Year	2018	2017	2016
Revenue	27.67	20.15	14.91
Revenue Growth	37.3%	35.17%	-
Gross Profit	16.79	10.30	7.77
Operating Income	-21.25	-18.97	-14.92
Net Income	-25.12	-21.28	-16.38
Shares Outstanding	1.40	1.32	1.13
Earnings Per Share	-17.97	-16.12	-14.50
Operating Cash Flow	-22.18	-24.00	-12.81
Capital Expenditures	-0.36	-0.82	-0.44
Free Cash Flow	-22.54	-24.81	-13.26
Cash & Equivalents	10.32	9.40	13.15
Total Debt	19.94	19.32	9.62
Net Cash / Debt	-9.62	-9.92	3.52
Assets	25.87	21.70	20.44
Liabilities	31.03	27.58	17.90
Book Value	-73.59	-49.52	-29.31

Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name	Avedro, Inc.
Employees	122
CEO	Reza Zadno

Stock Information

Ticker Symbol	AVDR
Stock Exchange	NASDAQ
Sector	Health Technology
Industry	Medical Specialties
Unique Identifier	NASDAQ: AVDR
IPO Date	February 14, 2019

Description

Avedro, an ophthalmic pharmaceutical and medical device company, develops and commercializes products to treat ophthalmic disorders and conditions, primarily associated with corneal weakness. The company's Avedro Corneal Remodeling platform comprises KXL and Mosaic systems, which deliver ultraviolet A or UVA light, and a suite of single-use riboflavin drug formulations. Its Avedro Corneal Remodeling platform treats corneal ectatic disorders and corrects refractive conditions; and KXL system in combination with Photrexa drug formulations used for the treatment of progressive keratoconus and corneal ectasia following refractive surgery. Avedro sells its products primarily to ophthalmologists, hospitals, and ambulatory surgery centers through a direct sales force in the United States, as well as through medical device distributors internationally. The company was formerly known as ThermalVision, Inc. and changed its name to Avedro, Inc. in October 2005. Avedro, Inc. was incorporated in 2002 and is headquartered in Waltham, Massachusetts.